ArticleExperimental hematology & oncology2015

Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma.

Francesco Pisani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.